Lekhram Changoer
Technik-/Wissenschafts-/F&E-Leiter bei CANAFARMA HEMP PRODUCTS CORP.
Vermögen: 2 Mio $ am 31.05.2024
Aktive Positionen von Lekhram Changoer
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CANAFARMA HEMP PRODUCTS CORP. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
INCANNEX HEALTHCARE INC. | Technik-/Wissenschafts-/F&E-Leiter | 28.06.2022 | - |
Stichting Sanammad | Direktor/Vorstandsmitglied | 01.01.2009 | - |
Corporate Officer/Principal | 01.01.2009 | - | |
Sanammad Pharmaceuticals BV | Direktor/Vorstandsmitglied | 01.01.2014 | - |
Corporate Officer/Principal | 01.01.2014 | - |
Karriereverlauf von Lekhram Changoer
Ehemalige bekannte Positionen von Lekhram Changoer
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AXIM BIOTECHNOLOGIES, INC. | Direktor/Vorstandsmitglied | 01.05.2014 | 06.05.2020 |
Technik-/Wissenschafts-/F&E-Leiter | 01.05.2014 | 06.05.2020 | |
APIRX Pharmaceuticals USA LLC
APIRX Pharmaceuticals USA LLC Pharmaceuticals: OtherHealth Technology APIRX Pharmaceuticals USA LLC is located in the US. Part of Incannex Healthcare, Inc., APIRX Pharmaceuticals USA LLC is an American company that provides research, development, and production of prescription pharmaceutical cannabinoid medicines. The company was founded by George E. Anastassov, Lekhram Changoer. APIRX Pharmaceuticals USA was acquired by Incannex Healthcare, Inc. on August 04, 2022 for $30.91 million. | Gründer | - | - |
CanChew Biotechnologies LLC
CanChew Biotechnologies LLC Pharmaceuticals: OtherHealth Technology CanChew Biotech focuses on the treatment of pain and other medical disorders with the application of chewing gum based cannabis/cannabinoids medical products. The company targets on the R&D and execution of their clinical development plan and subsequently out licensing of their technology. The development focuses on the R&D of the formulation, production and the development of chewing gum based products in their respective fields e.g.: for the treatment of numerous diseases like pain, nausea and vomiting, anorexia, spasticity and various other symptoms. | Direktor/Vorstandsmitglied | 01.01.2012 | - |
Technik-/Wissenschafts-/F&E-Leiter | 30.07.2013 | - | |
Gründer | 01.01.2012 | - |
Statistik
International
Vereinigte Staaten | 4 |
Niederlande | 4 |
Kanada | 2 |
Operativ
Director/Board Member | 4 |
Chief Tech/Sci/R&D Officer | 4 |
Founder | 2 |
Sektoral
Health Technology | 5 |
Miscellaneous | 2 |
Process Industries | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
INCANNEX HEALTHCARE INC. | Health Technology |
AXIM BIOTECHNOLOGIES, INC. | Health Technology |
CANAFARMA HEMP PRODUCTS CORP. | Process Industries |
Private Unternehmen | 4 |
---|---|
CanChew Biotechnologies LLC
CanChew Biotechnologies LLC Pharmaceuticals: OtherHealth Technology CanChew Biotech focuses on the treatment of pain and other medical disorders with the application of chewing gum based cannabis/cannabinoids medical products. The company targets on the R&D and execution of their clinical development plan and subsequently out licensing of their technology. The development focuses on the R&D of the formulation, production and the development of chewing gum based products in their respective fields e.g.: for the treatment of numerous diseases like pain, nausea and vomiting, anorexia, spasticity and various other symptoms. | Health Technology |
Stichting Sanammad | Miscellaneous |
Sanammad Pharmaceuticals BV | |
APIRX Pharmaceuticals USA LLC
APIRX Pharmaceuticals USA LLC Pharmaceuticals: OtherHealth Technology APIRX Pharmaceuticals USA LLC is located in the US. Part of Incannex Healthcare, Inc., APIRX Pharmaceuticals USA LLC is an American company that provides research, development, and production of prescription pharmaceutical cannabinoid medicines. The company was founded by George E. Anastassov, Lekhram Changoer. APIRX Pharmaceuticals USA was acquired by Incannex Healthcare, Inc. on August 04, 2022 for $30.91 million. | Health Technology |
- Börse
- Insiders
- Lekhram Changoer
- Erfahrung